Headache Medicine 2021, 12(4):323-327 p-ISSN 2178-7468, e-ISSN 2763-6178
323
ASAA
DOI: 10.48208/HeadacheMed.2021.53
Headache Medicine
© Copyright 2021
Original
Hyperacusis in migraine: pilot project
Bruna Colomera Maistro , Ana Clara Oliver Machado , Beatriz Bagatim Bossa , Valéria Aparecida Bello ,
Regina Célia Poli Frederico , Aline Vitali da Silva
Medical School, Pontifícia Universidade Católica do Paraná (PUC-PR), Londrina, Paraná, Brazil
Abstract
Introduction
Patients with migraine may report hearing disorders, such as hyperacusis and pho-
nophobia.
Objectives
To evaluate the prevalence and predictors of hyperacusis in patients with migraine.
Methods
A prospective case-control study was carried out at the specialties outpatient clinic of PUC-
-PR, campus Londrina. The present study included adult patients diagnosed with migraine.
Study participants completed a structured interview on demographic and anthropometric
data and clinical characteristics of migraine. They also completed validated questionnaires
on depression (BDI), anxiety (STAI2), disability (MIDAS), allodynia (ASC-12), and the
hyperacusis questionnaire. Two hundred seventy-six patients with migraine answered the
questionnaires. The participant was considered to have hyperacusis when the score was
greater than or equal to 22 points.
Results
We evaluated 276 individuals with migraine who answered the questionnaires, 162
without hyperacusis, and 114 with hyperacusis. Regarding the univariate analyses, epi-
sodic migraine (p=0.001; OR=2.28), phonophobia (p=0.017; OR=2.56), osmophobia
(p<0.001; OR=2.97) and allodynia (p<0.010; OR= 2.91) showed signicant results in
patients with hyperacusis. Patients without a trace of anxiety (p=0.007; OR=10.53) and
absence of depression (p=0.002; OR=2.89) were also related to hyperacusis.
As for multivariate analyses, patient characteristics that were signicantly associa-
ted with hyperacusis include episodic migraine (p=0.019; OR=2.029), osmophobia
(p=0.022; OR=2.214), and mild and moderate migraine-related disability. (p=0.022;
OR=2.158).
Conclusions
Patients with episodic migraine who have osmophobia and mild to moderate disability
related to this neurological disease are twice as likely to have hyperacusis, being consi-
dered important predictors of such hearing disorder. The presence or absence of aura
and photophobia did not present results with relevant statistical differences.
Bruna Colomera Maistro
maistrobruna@gmail.com
Edited by:
Marcelo Moraes Valença
Keywords:
Migraine
Hyperacusis
Phonophobia
Received: January, 15 2022
Accepted: February, 15 2022
324
ASAA
Maistro BC, Machado ACO, Bossa BB, Bello VA, Frederico RCP, Silva AV
Hyperacusis in migraine: pilot project
Introduction
M
igraine is a brain disorder that presents neurological
symptoms with headache attacks. The pain may be uni-
lateral, moderate to severe in intensity, associated with nausea,
vomiting, photophobia and phonophobia. There are even
cases of sensory, motor, and emotional impairment. In addi-
tion, it commonly has a family history.
1
Besides, migraine has
several distinct classications. Among these, the most relevant
are migraine with aura (before called as classic migraine), that
is usually preceded by visual, sensory, or language symptoms.
1
According to the International Headache Society, the
following criteria are used to diagnosemigraine without
aura.
2
A. At least 5 headache attacks in a lifetime;
B. Episodes lasting 4 to 72 hours when untreated or ineffectively
treated;
C. Headache with at least two of the following characteristics:
unilateral; pulsatile; moderate to severe pain; and worsening
of the condition with day-to-day activities or impossibility to
perform such activities due to intense pain;
D. Headache accompanied by at least one of the following:
nausea and/or vomiting; photophobia and phonophobia.
Balance disturbances such as rational vertigo, positional vertigo,
dizziness, and others have also been related during headache
attacks.
3-12
Thus, studies indicate that patients diagnosed with
migraine who have experienced kinetosis at some point in their
lives seem to be more susceptible to migraine attacks.
3,12-17
In addition, this type of headache may be associated to the
development of hearing disorders such as hyperacusis and
phonophobia.
18
Hyperacusis is an unpleasant sensation
caused by exposure to sound, due to a reduction in one's
tolerance.
19
It is characterized by increased sound sensation
in the auditory pathway and loss of the dynamic range of the
ear.
20
In the case of phonophobia, only certain sounds are
uncomfortable, while others can be comfortable even at high
intensities.
21
The primary difference between migraine with aura and
migraine associated with auditory-vestibular dysfunction is
the duration of the headache. In cases of migraine associated
with auditory vestibular dysfunction, symptoms may last for
hours, days, or weeks, while the symptoms of migraine with
aura last from seconds to 1 hour.
22
Another very characteristic symptom of migraine associated
with auditory-vestibular dysfunction is motion intolerance,
like kinetosis. Patients with such dysfunction report vertigo
whenever their head is in the trigger position.
23
Cases of
visual vertigo, which are usually induced by screens and
specic illumination, are also characteristic of the picture.
24
Hyperacusis can be diagnosed by Loudness Discomfort Level
(LDL)
25
, which will be responsible for evaluating the degree
of discomfort of a sound at each frequency.
26
The test starts
by presenting the sound from 50
25
or 60 dB NA, increasing
to 5dB with time, with stimulus onset at a frequency of 500
Hz amplifying to 1,000, 2,000 or 4,000 Hz
27
, and duration
of two seconds each stimulus, with a one-second interval
between stimuli.
25
The patient is instructed to notify the exact
moment the sound becomes uncomfortable.
27
The reference values for LDL were analyzed in two studies
of normal-hearing individuals without complaints of auditory
hypersensitivity, both studies obtained average results of the
level of discomfort from 100 dB NA.
27,28
In another study,
with the stimulus frequency ranging from 500 to 8,000 Hz,
the reference value of LDL for normal hearing was 86 to 98
dB NA.
25
In the study done in patients with hyperacusis, the LDL
reference values ranged between 50 and 90 dB HL. To
classify the degree of hyperacusis, the Johnson Hyperacusis
Dynamic Range Quotient (JHQ) which is given by subtracting
the LDL by the pure tone threshold (AL), this result is still
divided by the frequencies used in the study, to obtain the
JHQ, it is still necessary to add the dynamic ranges, divided
by the number of frequencies evaluated. The scale of the
degree of hyperacusis, from the JHQ, can be mild (75-90
dB), moderate (50-74 dB), severe (30-49 dB) or profound
(0-29 dB).
28
Also in the same study, a questionnaire was used to
differentiate between patients who have hyperacusis and
those who do not. The questionnaire is divided into three
parts. The rst part consists of questions about hypersensitivity
to sound, whether it is present, the degree and types of sound
that cause discomfort to the individual, triggers, and reactions
to hearing hypersensitivity. The second part addresses
questions about hearing loss and exposure to intense sound.
The third part is questions about personal background and
existing medical conditions, including migraine.
28
Two other studies used a unique questionnaire for patients with
hyperacusis, which assess which sounds are uncomfortable
and what the individual's reaction to uncomfortable sounds.
The sounds questioned in the studies are: loud music,
horns, people talking loudly, trafc noise, slamming doors,
sudden and loud sounds, dripping faucet, restaurant noise,
325
ASAA
Maistro BC, Machado ACO, Bossa BB, Bello VA, Frederico RCP, Silva AV
Hyperacusis in migraine: pilot project
doorbell, police siren, airplane, plastic bag noise, blender,
telephone ringing, loud laughter, airplane noises, barking
dogs, rearms, children crying, television at normal volume,
simultaneous conversation, and music at normal volume.
The behavioral reactions present in the questionnaire are
irritation, anxiety, need to leave the sound, tinnitus, tension,
disorientation, aggressiveness, pain, dizziness, anger,
shock, panic, fear, momentary stress, loss of concentration
and headache.
29,30
Method
After submission and approval of the research by the
Research Ethics Committee (no 3.029.972), a prospective
case-control study was carried out at the specialties
outpatient clinic of PUC-PR, campus Londrina. The present
study included patients diagnosed with migraine, 18 years
old or older and younger than 60 years old. Study participants
completed a structured interview on demographic and
anthropometric data and clinical characteristics of migraine.
They also completed validated questionnaires on depression
(BDI), anxiety (STAI2), disability (MIDAS), allodynia (ASC-12),
and the hyperacusis questionnaire. The questionnaires were
answered by 276 patients with migraine. The hyperacusis
questionnaire was composed of 14 questions to classify the
patients who have hyperacusis and those who do not have
hyperacusis. Each answer marked "no" corresponds to 0
points; "yes, a little" corresponds to 1 point; "yes, fairly"
corresponds to 2 points; and "yes, a lot" corresponds to 3
points. The participant was considered to have hyperacusis
when the score was greater than or equal to 22 points. In the
statistical analysis it was considered the signicance value
p<0.05.
Results and Discussion
We evaluated 276 individuals with migraine who answered
the applicable questionnaires, 162 without hyperacusis and
114 with hyperacusis. Results of univariate and multivariate
analyzes were obtained, relating patients with hyperacusis
according to age, sex, ethnicity, BMI, type of migraine,
presence of aura, phonophobia, photophobia, osmophobia,
allodynia, anxiety, depression and disability (Table 1).
Table 1. Comparative analysis of individuals without hyperacusis and with hyperacusis diagnosed with migraine.
Without hyperacusis N= 162 With hyperacusis N=114 Univaried Analysis Multivariate Analysis
Median
p
OR
p
OR
Age (median)
30 33 0.614 0.994
n (%) n (%)
Sex
Male 28 1 7. 3 0 11 9.60 0.073 1.96 0.555 1.296
Female 134 82.70 103 90.40
Ethnicity
Caucasian 135 83.30 92 80.70 0.573 1.2 0.620 0.83
Non caucasian 27 16.70 22 19.30
BMI_dico_29_30
Without obesity (BMI<30) 135 83.90 93 81.60 0.622 1.17 0.637 0.829
Obesity (BMI≥30) 26 16.10 21 18.40
Migraine Type
Episodic 113 70.60 58 51.30 0.001* 2.28 0.019 2.029
Chronic 47 29.40 55 48.70
Migraine with aura
No 103 63.60 67 58.80 0.419 1.22 0.935 1.025
Yes 59 36.40 47 41.20
Phonophobia
No 29 18.00 9 7. 90 0.017* 2.56 0.090 2.221
Yes 132 82.00 105 92.10
Photophobia
No 10 6.20 7 6.10 0.981 1.01 0.482 0.643
Yes 151 93.80 107 93.90
Osmophobia
No 62 38.30 19 17.30% <0.001* 2.97 0.022 2.214
Yes 100 61.70 91 82.70%
ASC12_dico
Mild or none (0-5) 97 60.20 39 34.20% <0.001* 2.91 0.056 1.773
Moderate to severe (≥6) 64 39.80 75 65.80%
Anxiety-Trait
Without anxiety 161 99.40 107 93.90% 0.007*,b 10.53 0.224 4.179
With anxiety 1 0.60 7 6.10%
Depression
Without depression 147 90.70 88 77.20% 0.002* 2.89 0.153 1.868
With depression 15 9.30 26 22.80%
MIDAS_dico10_11
Mild disability or none 143 90.50 88 77.20% 0.002* 2.81 0.022 2.518
Moderate to severe disability 15 9.50 26 22.80%
326
ASAA
Maistro BC, Machado ACO, Bossa BB, Bello VA, Frederico RCP, Silva AV
Hyperacusis in migraine: pilot project
Regarding the univariate analyses, episodic migraine
(p=0.001; OR=2.28), phonophobia (p=0.017; OR=2.56),
osmophobia (p<0.001; OR=2.97) and allodynia (p<0.010;
OR= 2.91) showed signicant results in patients with
hyperacusis. Patients without trace of anxiety (p=0.007;
OR=10.53) and absence of depression (p=0.002;
OR=2.89) were also related to hyperacusis.
As for multivariate analyses, patient characteristics that
were signicantly associated with hyperacusis include
episodic migraine (p=0.019; OR=2.029), osmophobia
(p=0.022; OR=2.214), and mild and moderate migraine-
related disability. (p=0.022; OR=2.158).
Conclusion
Patients with episodic migraine who have osmophobia
and mild to moderate disability related to this neurological
disease are twice as likely to have hyperacusis, being
considered important predictors of such hearing disorder.
The presence or absence of aura and photophobia did
not present results with relevant statistical differences
(p>0.05).
Author’s contribution: BCM, ACOM, BBB, manuscript
writing; manuscrip design; analysis of data; review;
approval of the nal version. VAB, RCPF, AVS study
conception and design; manuscript e review; approval of
the nal version.
Financing: there was no funding.
Conflict of interest: the authors declare is not conict of
interest.
Bruna Colomera Maistro
https://orcid.org/0000-0001-8360-8801
Ana Clara Oliver Machado
https://orcid.org/0000-0001-6469-2462
Beatriz Bagatim Bossa
https://orcid.org/0000-0001-5538-1689
Valéria Aparecida Bello
https://orcid.org/0000-0001-7919-6218
Regina Célia Poli Frederico
https://orcid.org/0000-0003-4631-4606
Aline Vitali da Silva
https://orcid.org/0000-0001-7797-9227
References
1. Silva WF. Diagnóstico das cefaléias. São Paulo:
Lemos Editorial; 2003.
2. Classification and diagnostic criteria for headache
disorders, cranial neuralgias and facial pain.
Headache Classification Committee of the
International Headache Society.
Cephalalgia
1988;8
Suppl 7:1-96
3. Symonds CP. Vertigo.
Postgrad Med J
1926;1(5):63-
65 Doi:10.1136/pgmj.1.5.63
4. Boenheim F. Über familiäre Hemicrania vestibularis.
Neurol Centralbl
1917;36:226-229.
5. Heveroch M. La migraine vestibulaire.
Rev Neurol
1925;33:925-929
6. Richter H. Die migraine. In: Bumke O and Foerster
O, editors. Handbuch der neurologie. 17 ed. Berlin:
Springer; 1935. p. 166-245.
7. Heych H. Der kopfschmerz: differentialdiagnostik
und therapie fur die praxis. 2 ed. Stuttgard: G.
Thieme; 1958.
8. Wolff HG. Headache and other head pain. 1 ed. New
York (NY): Oxford University Press; 1963. 648 p.
9. Bikhazi P, Jackson C and Ruckenstein MJ. Efficacy of
antimigrainous therapy in the treatment of migraine-
associated dizziness.
Am J Otol
1997;18(3):350-354
10. Brantberg K, Trees N and Baloh RW. Migraine-associated
vertigo.
Acta Otolaryngol
2005;125(3):276-279
Doi:10.1080/00016480510003165
11. Neuhauser HK and Lempert T. Diagnostic criteria for
migrainous vertigo.
Acta Otolaryngol
2005;125 (11):
1247-1248 Doi:10.1080/00016480510040137
12. Shepard NT. Differentiation of Ménière's disease
and migraine-associated dizziness: a review. J
Am
Acad Audiol
2006;17(1):69-80 Doi:10.3766/
jaaa.17.1.7
13. Fedorova ML. Vestibular syndrome in migraine. Klin
Med (Mosk) 1970;48(5):70-76
14. Pearce J. Some aethiological factors in migraine. In:
Cummings JN, editor. Background to migraine. 4 ed.
London: Heinemann Medical; 1970. p. 1-7.
15. Kuritzky A, Toglia UJ and Thomas D. Vestibular
function in migraine.
Headache
1981;21(3):110-112
Doi:10.1111/j.1526-4610.1981.hed2103110.x
16. Cass SP, Furman JM, Ankerstjerne K, Balaban C, Yetiser
S and Aydogan B. Migraine-related vestibulopathy.
Ann Otol Rhinol Laryngol
1997;106(3):182-189
Doi:10.1177/000348949710600302
17. Reploeg MD and Goebel JA. Migraine-associated
dizziness: patient characteristics and management
options.
Otol Neurotol
2002;23(3):364-371
Doi:10.1097/00129492-200205000-00024
18. Sacks OW. Migraine: the evolution of a common
disorder. 1 ed. London: Faber & Faber; 1970. 197 p.
19. Katzenell U and Segal S. Hyperacusis: review and
clinical guidelines.
Otol Neurotol
2001;22(3):321-
327
ASAA
Maistro BC, Machado ACO, Bossa BB, Bello VA, Frederico RCP, Silva AV
Hyperacusis in migraine: pilot project
326 Doi:10.1097/00129492-200105000-00009
20. Centro de Acúfenos de Buenos Aires. Hiperacusia
[Internet]. 2002 Available from: http://www.acufeno.
com.
21. Coles AAA, Sook SK. Hyperacusis and phonophobia
in hyperacusic and non hyperacusis subjects.
Br J
Audiol
1988;22:228
22. Kayan A and Hood JD. Neuro-otological manifestations
of migraine.
Brain
1984; 107 (Pt 4):1123-1142
Doi:10.1093/brain/107.4.1123
23. Ishiyama A, Jacobson KM and Baloh RW.
Migraine and benign positional vertigo.
Ann
Otol Rhinol Laryngol
2000;109(4):377-380
Doi:10.1177/000348940010900407
24. Cal R and Bahmad JF. Enxaqueca associada a
disfunção auditivo-vestibular.
Rev Bras Otorrinolaringol
2008;74(4):606-612 Doi:10.1590/s0034-
72992008000400020
25. Knobel KAB and Sanchez TG. Nível de desconforto para
sensação de intensidade em indivíduos com audição
normal.
Pró-Fono R Atual Cient
2006;18(1):31-40
Doi:10.1590/s0104-56872006000100005
26. Sanchez TGP, Bovino ME and Bento RF. Hiperacusia:
artigo de revisão.
Int Arch Otorhinolaryngol
1999;3(4):184-188.
27. Sherlock LP and Formby C. Estimates of Loudness,
Loudness Discomfort, and the Auditory Dynamic
Range: Normative Estimates, Comparison of
Procedures, and Test-Retest Reliability.
J Am
Acad Audiol
2005;16(2):85-100 Doi:10.3766/
jaaa.16.2.4
28. Ribeiro AEFC. Pesquisa do limiar de desconforto
auditivo em pacientes com hipersensibilidade
auditiva.
Distúrb Comun
2007;19(2):181-192.
29. Urnau D and Tochetto TM. Características do
zumbido e da hiperacusia em indivíduos normo-
ouvintes.
Arq Int Otorrinolaringol
2011;15(4):468-
474 Doi:10.1590/s1809-48722011000400010
30. Gonçalves MS, Tochetto TM and Gambini C.
Hiperacusia em músicos de banda militar.
Rev
Sociedade Bras Fonoaudiol
2007;12(4):298-303
Doi:10.1590/s1516-80342007000400008